IOVANCE BIOTHERAPEUTICS, INC.
Biopharmaceutical company developing personalized TIL cell therapies for cancer.
IOVA | US
Overview
Corporate Details
- ISIN(s):
- US4622601007
- LEI:
- Country:
- United States of America
- Address:
- 825 INDUSTRIAL ROAD, 94070 SAN CARLOS
- Website:
- https://www.iovance.com/
- Sector:
- Manufacturing
Description
Iovance Biotherapeutics, Inc. is a commercial-stage biopharmaceutical company focused on innovating, developing, and delivering cell therapies for cancer. The company's core technology is Tumor Infiltrating Lymphocyte (TIL) therapy, a personalized immunotherapy that harnesses a patient's own immune system. The process involves extracting T-cells from a patient's tumor, expanding them, and re-infusing them to recognize and attack cancer cells by targeting unique neoantigens. Iovance is investigating its T-cell-based therapies in clinical trials for various advanced solid tumors, such as metastatic melanoma. The company is also advancing genetically modified TIL therapies as a next-generation approach to cancer treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all IOVANCE BIOTHERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IOVANCE BIOTHERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IOVANCE BIOTHERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
